{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T14:56:00Z","timestamp":1702911360356},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T00:00:00Z","timestamp":1676937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T00:00:00Z","timestamp":1676937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-023-01005-4","type":"journal-article","created":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T20:38:17Z","timestamp":1677011897000},"page":"2267-2273","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comparison of immune response to SARS-COV-2 vaccine in COVID-recovered versus non-infected Individuals"],"prefix":"10.1007","volume":"23","author":[{"given":"Saadiya","family":"Mushtaq","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Khalid","family":"Azam Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Qaiser","family":"Alam Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Ali","family":"Rathore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bushra","family":"Parveen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misbah","family":"Noor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eijaz","family":"Ghani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aamir Bin","family":"Tahir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamid Nawaz","family":"Tipu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biaoyang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,21]]},"reference":[{"issue":"3","key":"1005_CR1","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41579-020-00468-6","volume":"19","author":"P V\u2019kovski","year":"2021","unstructured":"V\u2019kovski P, Kratzel A, Steiner S, Stalder H, Thiel V. Coronavirus biology and replication: implications for SARS-CoV-2. Nat Rev Microbiol. 2021;19(3):155\u201370.","journal-title":"Nat Rev Microbiol"},{"key":"1005_CR2","doi-asserted-by":"publisher","first-page":"m3018","DOI":"10.1136\/bmj.m3018","volume":"370","author":"HF Sewell","year":"2020","unstructured":"Sewell HF, Agius RM, Stewart M, Kendrick D. Cellular immune responses to COVID-19. BMJ. 2020;370:m3018.","journal-title":"BMJ"},{"key":"1005_CR3","doi-asserted-by":"publisher","first-page":"eabf4063","DOI":"10.1126\/science.abf4063","volume":"371","author":"JM Dan","year":"2021","unstructured":"Dan JM, Mateus J, Kato Y, et al. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. Science. 2021;371:eabf4063.","journal-title":"Science"},{"key":"1005_CR4","doi-asserted-by":"crossref","unstructured":"Goldberg Y, Mandel M, Woodbridge Y, et al. Protection of previous SARS-CoV-2 infection is similar to that of BNT162b2 vaccine protection. A three-month nationwide experience from Israel. medRxiv. 2021.","DOI":"10.1101\/2021.04.20.21255670"},{"key":"1005_CR5","doi-asserted-by":"crossref","unstructured":"Baden LR, El Sahly HM, Essink B, et al. COVE Study Group. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021;384(5);403\u201316.","DOI":"10.1056\/NEJMoa2035389"},{"key":"1005_CR6","doi-asserted-by":"crossref","unstructured":"Polack FP, Thomas SJ, Kitchin N, et al. C4591001 Clinical Trial Group. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. N Engl J Med. 2020;383(27):2603\u201315.","DOI":"10.1056\/NEJMoa2034577"},{"key":"1005_CR7","doi-asserted-by":"crossref","unstructured":"Logunov DY, Dolzhikova IV, Shcheblyakov DV, et al. Gam-COVID-Vac Vaccine Trial Group. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomized controlled phase 3 trial in Russia. Lancet. 2021;397(10275):671\u201381.","DOI":"10.1016\/S0140-6736(21)00234-8"},{"key":"1005_CR8","doi-asserted-by":"crossref","unstructured":"Voysey M, Clemens SAC, Madhi SA, et al. Oxford COVID Vaccine Trial Group. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomized controlled trials in Brazil, South Africa, and the UK. Lancet. 2021;397(10269):99\u2013111.","DOI":"10.1016\/S0140-6736(20)32661-1"},{"issue":"1","key":"1005_CR9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1001\/jama.2021.8565","volume":"326","author":"N Al Kaabi","year":"2021","unstructured":"Al Kaabi N, Zhang Y, Xia S, et al. Effect of 2 inactivated SARS-CoV-2 vaccines on symptomatic COVID-19 infection in adults: a randomized clinical trial. JAMA. 2021;326(1):35\u201345.","journal-title":"JAMA"},{"key":"1005_CR10","doi-asserted-by":"crossref","unstructured":"Nadeem I, Ul Munamm SA, Ur Rasool M, Fatimah M, Abu Bakr M, Rana ZK, et al. Safety and efficacy of Sinopharm Vaccine (BBIBP-CorV) in elderly population of Faisalabad district of Pakistan. Postgrad Med J. 2022; postgradmedj-2022-141649.","DOI":"10.1136\/postgradmedj-2022-141649"},{"issue":"2","key":"1005_CR11","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/S1473-3099(21)00462-X","volume":"22","author":"S Xia","year":"2022","unstructured":"Xia S, Zhang Y, Wang Y, Wang H, Yang Y, Gao GF, et al. Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-Cor V, in people younger than 18 years: a randomized, double-blind, controlled, phase 1\/2 trial. Lancet Infect Dis. 2022;22(2):196\u2013208.","journal-title":"Lancet Infect Dis"},{"key":"1005_CR12","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1001\/jama.2022.1393","volume":"327","author":"JL Alejo","year":"2022","unstructured":"Alejo JL, Mitchell J, Chang A, Chiang TPY, Massie AB, Segev DL, et al. Prevalence and durability of SARS-CoV-2 antibodies among unvaccinated US adults by history of COVID-19. JAMA. 2022;327:1085\u20137.","journal-title":"JAMA"},{"issue":"15","key":"1005_CR13","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1001\/jama.2021.15125","volume":"326","author":"D Steensels","year":"2021","unstructured":"Steensels D, Pierlet N, Penders J, Mesotten D, Heylen L. Comparison of SARS-CoV-2 antibody response following vaccination with BNT162b2 and mRNA-1273. JAMA. 2021;326(15):1533\u20135.","journal-title":"JAMA"},{"issue":"5","key":"1005_CR14","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3390\/tropicalmed7050066","volume":"7","author":"JC G\u00f3mez de laTorre","year":"2022","unstructured":"G\u00f3mez de laTorre JC, C\u00e1ceres-Del Aguila JA, Muro-Rojo C, De La Cruz-Escurra N, Copaja-Corzo C, Hueda-Zavaleta M, et al. Humoral immune response induced by the BBIBP-CorV Vaccine (Sinopharm) in healthcare workers: a Cohort Study. Trop Med Infect Dis. 2022;7(5):66.","journal-title":"Trop Med Infect Dis"},{"key":"1005_CR15","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","volume":"27","author":"DS Khoury","year":"2021","unstructured":"Khoury DS, Cromer D, Reynaldi A, Schlub TE, Wheatley AK, Juno JA, et al. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat Med. 2021;27:1205\u201311.","journal-title":"Nat Med"},{"issue":"6","key":"1005_CR16","doi-asserted-by":"publisher","first-page":"e240","DOI":"10.1016\/S2666-5247(21)00025-2","volume":"2","author":"WN Chia","year":"2021","unstructured":"Chia WN, Zhu F, Ong SWX, Young BE, Fong SW, Le Bert N, et al. Dynamics of SARS-CoV-2 neutralizing antibody responses and duration of immunity: a longitudinal study. Lancet Microbe. 2021;2(6):e240\u20139.","journal-title":"Lancet Microbe"},{"key":"1005_CR17","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1038\/s41564-021-00947-3","volume":"6","author":"J Wei","year":"2021","unstructured":"Wei J, Stoesser N, Matthews PC, Ayoubkhani D, Studley R, Bell I, et al. Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom. Nat Microbiol. 2021;6:1140\u20139.","journal-title":"Nat Microbiol"},{"key":"1005_CR18","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.tjog.2020.09.006","volume":"59","author":"WH Chang","year":"2020","unstructured":"Chang WH. A review of vaccine effects on women in light of the COVID-19 pandemic. Taiwan J Obstet Gynecol. 2020;59:812\u201320.","journal-title":"Taiwan J Obstet Gynecol"},{"key":"1005_CR19","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nri.2016.90","volume":"16","author":"SL Klein","year":"2016","unstructured":"Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16:626\u201338.","journal-title":"Nat Rev Immunol"},{"key":"1005_CR20","unstructured":"World Health Organization. Clinical management of COVID-19: Interim Guidance. World Health Organization. 2020: 13\u201315."},{"key":"1005_CR21","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.3390\/vaccines9121508","volume":"9","author":"B Wolszczak-Biedrzycka","year":"2021","unstructured":"Wolszczak-Biedrzycka B, Bienkowska A, Dorf J. Assessment of post-vaccination antibody response eight months after the administration of BNT1622b2 vaccine to health care workers with particular emphasis on the impact of previous COVID-19 infection. Vaccines. 2021;9:1508.","journal-title":"Vaccines"},{"issue":"635","key":"1005_CR22","doi-asserted-by":"publisher","first-page":"eabm 7853","DOI":"10.1126\/scitranslmed.abm7853","volume":"14","author":"S Chakraborty","year":"2022","unstructured":"Chakraborty S, Gonzalez JC, Sievers BL, Mallajosyula V, Chakraborty S, Dubey M, et al. Early non-neutralizing afucosylated antibody responses are associated with COVID-19 severity. Sci Transl Med. 2022;14(635):eabm 7853.","journal-title":"Sci Transl Med"},{"key":"1005_CR23","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12985-021-01530-2","volume":"18","author":"J Chansaenroj","year":"2021","unstructured":"Chansaenroj J, Yorsaeng R, Posuwan N, Puenpa J, Sudhinaraset N, Chirathaworn C, et al. Detection of SARS-CoV-2 specific antibodies via rapid diagnostic immunoassays in COVID-19 patients. Viro J. 2021;18:52.","journal-title":"Viro J"},{"issue":"10279","key":"1005_CR24","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/S0140-6736(21)00501-8","volume":"397","author":"C Manisty","year":"2021","unstructured":"Manisty C, Otter AD, Treibel TA, McKnight A, Altmann DM, Brooks T, et al. Antibody response to first BNT162b2 dose in previously SARS-CoV-2 infected individuals. Lancet. 2021;397(10279):1057\u20138.","journal-title":"Lancet"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-023-01005-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-023-01005-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-023-01005-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T17:16:22Z","timestamp":1696094182000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-023-01005-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,21]]},"references-count":24,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["1005"],"URL":"https:\/\/doi.org\/10.1007\/s10238-023-01005-4","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,21]]},"assertion":[{"value":"31 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol was approved by Research Review Board Combined Military Hospital Lahore (IRB number 350\/2021). The study was carried out after taking informed consent from study participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The study was carried out after taking informed consent from study participants for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}